However, other large-scale genomics projects using a different baseline (diploid tumor samples instead of normal prostate tissue) have suggested that Plexin-B1 upregulation is more common than its decrease [cBioportal (56, 57) summarized in Supplementary Table S3]. The gene discussed is PLXNB1; the disease is neoplasm.